Advanced Search
Now showing items 1-10 of 14
Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
(American Chemical Society, 2017)
Aminochrome as new preclinical model to find new pharmacological treatment that stop the development of parkinsons disease
(Bentham Science Publishers B.V., 2016)
Aminochrome as preclinical model for Parkinson's disease
(Impact Journals LLC, 2017)
The need of a new and more physiological preclinical model for Parkinson's disease
(Birkhauser Verlag AG, 2016)
Commentary: Gene therapy: A promising approach for neuroprotection in Parkinson’s disease?
(Frontiers Media S.A., 2017)
Commentary: Evaluation of models of Parkinson's disease
(Frontiers Media S.A., 2016)
Neurotoxins as Preclinical Models for Parkinson’s Disease
(Springer New York LLC, 2018)
Commentary: Evaluation of Models of Parkinson's Disease
(Frontiers Media, 2016-04)